These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22277036)

  • 1. [Keratin fragments as a serological indicator in patients with a liver disease].
    Lata J; Mrlianová H; Stibůrek O; Nozicka J; Cermáková Z; Gottwaldová J; Drozd P
    Vnitr Lek; 2011 Dec; 57(12):1025-8. PubMed ID: 22277036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation.
    Yagmur E; Trautwein C; Leers MP; Gressner AM; Tacke F
    Clin Biochem; 2007 Jun; 40(9-10):651-5. PubMed ID: 17306787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.
    Esmaeil N; Moayedi B; Gharagozloo M; Maracy MR
    Hemoglobin; 2013; 37(4):404-10. PubMed ID: 23600495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis.
    Valva P; De Matteo E; Galoppo MC; Gismondi MI; Preciado MV
    J Med Virol; 2010 May; 82(6):949-57. PubMed ID: 20419808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
    Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.
    Eren F; Yilmaz Y; Kose S; Ozdemir FT; Yonal O; Kurt R; Ozdogan O; Avsar E
    Clin Chim Acta; 2010 Dec; 411(23-24):2029-32. PubMed ID: 20807521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases.
    Gonzalez-Quintela A; Mallo N; Mella C; Campos J; Perez LF; Lopez-Rodriguez R; Tome S; Otero E
    Liver Int; 2006 Dec; 26(10):1217-24. PubMed ID: 17105587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis.
    Gonzalez-Quintela A; Abdulkader I; Campos J; Fernandez-Hernandez L; Lojo S
    Dig Dis Sci; 2009 Mar; 54(3):648-53. PubMed ID: 18618253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis.
    Tarantino G; Conca P; Coppola A; Vecchione R; Di Minno G
    Eur J Clin Invest; 2007 Jan; 37(1):48-53. PubMed ID: 17181567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation.
    Giovanella L; Ceriani L; Bandera M; Rimoldi R; Beghé B; Roncari G
    Q J Nucl Med; 1995 Dec; 39(4):285-9. PubMed ID: 8624791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of tissue polypeptide specific antigen as a marker in liver diseases.
    Cetin T; Oğuz A; Algan P; Yildirim IS
    Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.
    Ausch C; Buxhofer-Ausch V; Olszewski U; Hinterberger W; Ogris E; Schiessel R; Hamilton G
    Eur J Surg Oncol; 2009 Nov; 35(11):1164-8. PubMed ID: 19254831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival.
    Ulukaya E; Yilmaztepe A; Akgoz S; Linder S; Karadag M
    Lung Cancer; 2007 Jun; 56(3):399-404. PubMed ID: 17316892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of apoptosis and M30 expression in colonic cancer progression.
    Kykalos S; Dimitroulis D; Ntikoudi E; Karayiannakis A
    J Recept Signal Transduct Res; 2013 Aug; 33(4):255-9. PubMed ID: 23767766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis.
    González-Quintela A; Mella C; Pérez LF; Abdulkader I; Caparrini AM; Lojo S
    Alcohol Clin Exp Res; 2000 Aug; 24(8):1222-6. PubMed ID: 10968661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokeratin 18 as an indicator of the activity of liver disease].
    Luto M; Jaroszewicz J; Flisiak R
    Pol Merkur Lekarski; 2011 Dec; 31(186):331-4. PubMed ID: 22239000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-polypeptide-specific antigen levels in diabetic patients with normal and pathological biochemical profiles.
    Rodriguez J; Varela-Calviño R; Garrido Outeiriño M; Rodríguez-Segade S; Camiña F
    Clin Biochem; 2007 Feb; 40(3-4):278-81. PubMed ID: 17208209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma.
    Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
    Anticancer Res; 2002; 22(6B):3793-6. PubMed ID: 12552995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcoholic and non-alcoholic hepatic disease.
    Milman N; Graudal N; Hegnhøj J; Christoffersen P; Pedersen NS
    Hepatogastroenterology; 1994 Feb; 41(1):20-4. PubMed ID: 8175108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.